SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Karas Kevin R

(Last) (First) (Middle)
C/O NATIONAL RESEARCH CORPORATION
1245 Q STREET

(Street)
LINCOLN NE 68508

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NATIONAL RESEARCH CORP [ NRCIA/B ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP Finance, CFO, Treas & Secy
3. Date of Earliest Transaction (Month/Day/Year)
01/03/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 13,805 D
Class B Common Stock 2,355 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $10.75 (1) 01/05/2022 Class A Common Stock 26,403 26,403 D
Employee Stock Option (right to buy) $14.5 (2) 01/07/2023 Class A Common Stock 20,088 20,088 D
Employee Stock Option (right to buy) $18.8 (3) 01/07/2024 Class A Common Stock 5,334 5,334 D
Employee Stock Option (right to buy) $13.17 (4) 01/06/2025 Class A Common Stock 19,313 19,313 D
Employee Stock Option (right to buy) $10.75 (5) 01/05/2026 Class A Common Stock 20,458 20,458 D
Employee Stock Option (right to buy) $18.8 (6) 01/04/2027 Class A Common Stock 16,728 16,728 D
Employee Stock Option (right to buy) $36.8 01/03/2018 A 11,617 (7) 01/03/2028 Class A Common Stock 11,617 $0 11,617 D
Employee Stock Option (right to buy) $21.5 (1) 01/05/2022 Class B Common Stock 4,400 4,400 D
Employee Stock Option (right to buy) $27.13 (2) 01/07/2023 Class B Common Stock 3,348 3,348 D
Employee Stock Option (right to buy) $34.15 (3) 01/07/2024 Class B Common Stock 489 489 D
Employee Stock Option (right to buy) $35.48 (4) 01/06/2025 Class B Common Stock 3,219 3,219 D
Employee Stock Option (right to buy) $34 (5) 01/05/2026 Class B Common Stock 3,410 3,410 D
Employee Stock Option (right to buy) $40.54 (6) 01/04/2027 Class B Common Stock 2,788 2,788 D
Explanation of Responses:
1. This option became fully exercisable on January 5, 2017.
2. This option becomes fully exercisable on January 7, 2018.
3. This option becomes fully exercisable on January 7, 2019.
4. This option becomes fully exercisable on January 6, 2020.
5. This option becomes fully exercisable on January 5, 2021.
6. This option becomes fully exercisable on January 4, 2022.
7. This option becomes fully exercisable on January 3, 2023.
/s/ Russell E. Ryba, Attorney-in-Fact for Kevin R. Karas 01/04/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.